T-cell-rich B-cell lymphoma-diagnostic and therapeutic aspects

APMIS

Volumn 110, Issue 5, 2002, Pages 379-390

  Axdorph, Ulla ^a   Porwit Macdonald, Anna ^a   Sjøberg, Jan ^a   Grimfors, Gunnar ^a   Bjørkholm, Magnus ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CD3 chain; Hodgkin's disease; Immunohistochemistry; Lymphoma classification; Prognosis; T cell rich B cell lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; GRANZYME B; LATENT MEMBRANE PROTEIN 1; T CELL INTRACELLULAR ANTIGEN 1; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BONE MARROW METASTASIS; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER INFILTRATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; EVALUATION; FEMALE; GENDER; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INGUINAL LYMPH NODE; LYMPH NODE METASTASIS; LYMPHOMA CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; SPLENOMEGALY; SWEDEN; T CELL RICH B CELL LYMPHOMA; T LYMPHOCYTE; TUMOR BIOPSY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BIOPSY; CARRIER PROTEINS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRANZYMES; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOMA, B-CELL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLY(A)-BINDING PROTEINS; PROTEINS; RETROSPECTIVE STUDIES; RNA-BINDING PROTEINS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES;

EID: 0036082542     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2002.100503.x     Document Type: Article

References (53)

1. Large B-cell lymphoma rich in T cells and simulating Hodgkin's disease
2. T-cell-rich B-cell lymphomas: A clinicopathologic study of 19 cases
3. T-cell-rich B-cell lymphoma
4. T-cell rich B-cell lymphoma masquerading as Hodgkin disease: Excellent outcome to inadequate therapy
5. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease
6. T cell rich B cell lymphoma (TCRBCL): Study of sixteen cases with review of literature
7. T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease
8. European task force on lymphoma project on lymphocyte predominance Hodgkin disease: Histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes
9. T-cell-rich B-cell lymphomas: Diagnosis and response to therapy of 44 patients
10. Peripheral T-cell lymphoma complicated by a proliferation of large B-cells
11. Molecular analysis of single B-cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells
12. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
13. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November, 1997
14. T-cell-rich B-cell lymphoma - A distinct clinicopathologic entity?
15. T-cell-rich B-cell lymphoma
16. Large B-cell lymphomas with a high content of reactive T cells
17. H rearrangement
18. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma and paragranuloma by paraffin immunohistochemistry
19. Hodgkin's lymphomas: Classification, diagnosis, and grading
20. Hodgkin's and non-Hodgkin's lymphoma: Spectrum of morphologic and immunophenotypic overlap
21. T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness
22. Interleukin-4 may contribute to the abundant T-cell reaction and paucity of neoplastic B-cells in T-cell-rich B-cell lymphomas
23. Decreased expression of the signal transducing ζ chains in tumor-infiltrating T-cells and NK-cells of patients with colorectal carcinoma
24. Alterations in signal transducing molecule CD3 ζ in patients with neoplastic diseases
25. Absent or low expression of the ζ chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma
26. Expression of CD3-ζ on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes
27. Immunological escape mechanisms in pancreatic carcinoma
28. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function
29. The radical radiotherapy regionally localized of Hodgkin's Disease
30. The role of radiation therapy in the management of the non- Hodgkin's lymphomas
31. CHOP vs MEV for the treatment of non-Hodgkin's lymphoma of unfavourable histopathology: A randomized clinical trial
32. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
33. Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma
34. T-cell-rich B-cell lymphoma. A clinicopathologic study of eight cases
35. Bone marrow involvement in T-cell-rich B-cell lymphoma
36. T-cell rich B-cell non-Hodgkin's lymphoma: A progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease
37. Report of the Committee on Hodgkin's disease staging classification
38. Simultaneously presenting aplastic anaemia and Hodgkin's disease successfully treated with allogeneic bone marrow transplantation
39. Fixed versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease
40. Nonparametric estimation from incomplete observations
41. A generalised Wilcoxon test for comparing arbitrarily single-censored samples
42. Hodgkin's disease in patients older than 70 years of age: A registry-based analysis
43. Immune escape mechanisms in Hodgkin's disease
44. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T-cells, show increased tumor cell apoptosis, and have lower bcl-2 expression than diffuse large B-cell lymphomas
45. Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: Immunophenotypic and molecular studies
46. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma
47. Lymphocyte predominance Hodgkin's disease: The use of bcl-6 and CD57 in diagnosis and differential diagnosis
48. Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: An independent biological prognostic marker
49. All infiltrating T-lymphocytes in Hodgkin's disease express immunohistochemically detectable T-cell receptor ζ-chains in situ
50. Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease